SCHEMBL2661544

SCHEMBL2661544

CC(C)C(O)c1cc(C(=O)Nc2nccs2)n(Cc2ccc(F)c(C(F)(F)F)c2)c1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 6/20 0.45
KMT2A Q03164 6/20 0.45
ALDH1A1 P00352 4/20 0.45
HPGD P15428 3/20 0.45
NPSR1 Q6W5P4 2/20 0.45
HSD17B10 Q99714 2/20 0.45
TSHR P16473 1/20 0.45
MAPK1 P28482 1/20 0.45
RECQL P46063 1/20 0.45
RXFP1 Q9HBX9 2/20 0.43
KDM4E B2RXH2 2/20 0.40
RAB9A P51151 4/20 0.39
NPC1 O15118 3/20 0.39
ADORA2A P29274 3/20 0.38
SMN1; SMN2 Q16637 3/20 0.38
ADORA1 P30542 2/20 0.38
LMNA P02545 1/20 0.38
XBP1 P17861 1/20 0.38
ADORA2B P29275 1/20 0.37
GAA P10253 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2660617 0.91 MEN1 (0.48) MEN1KMT2AALDH1A1HPGDNPSR1
SCHEMBL13504179 0.87 SCD (0.41) LMNATP53NR3C2
SCHEMBL2662021 0.86 MEN1 (0.46) MEN1KMT2AALDH1A1HPGDNPSR1
SCHEMBL15104045 0.86 LMNA (0.36) MEN1KMT2AALDH1A1HPGDNPSR1
SCHEMBL2661902 0.86 MEN1 (0.45) MEN1KMT2AALDH1A1HPGDNPSR1
SCHEMBL13504176 0.85 SCD (0.40) LMNATP53
SCHEMBL2660655 0.81 GCK (0.47) MEN1KMT2AALDH1A1HPGDNPSR1
SCHEMBL3754530 0.80 GCK (0.41) LMNATP53
SCHEMBL2661487 0.80 RXRA (0.41) LMNATP53
SCHEMBL3756299 0.80 MEN1 (0.46) MEN1KMT2AALDH1A1HPGDNPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2155720-B1 PYRROLE-2-CARBOXAMIDE DERIVATIVES AS GLUCOKINASE ACTIVATORS, THEIR PROCESS AND PHARMACEUTICAL APPLICATION ADVINUS THERAPEUTICS PRIVATE LTD (IN) 2013-07-17 EP claimed
US-8299115-B2 Pyrrole-2-carboxamide derivatives as glucokinase activators, their process and pharmaceutical application ADVINUS THERAPEUTICS PRIVATE LIMITED (IN) 2012-10-30 US claimed
US-20100292143-A1 PYRROLE-2-CARBOXAMIDE DERIVATIVES AS GLUCOKINASE ACTIVATORS, THEIR PROCESS AND PHARMACEUTICAL APPLICATION ADVINUS THERAPEUTICS PRIVATE LIMITED (IN) 2010-11-18 US claimed
EP-2155720-A1 PYRROLE-2-CARBOXAMIDE DERIVATIVES AS GLUCOKINASE ACTIVATORS, THEIR PROCESS AND PHARMACEUTICAL APPLICATION Advinus Therapeutics Private Limited (IN) 2010-02-24 EP claimed
WO-2008149382-A1 PYRROLE-2-CARBOXAMIDE DERIVATIVES AS GLUCOKINASE ACTIVATORS, THEIR PROCESS AND PHARMACEUTICAL APPLICATION ADVINUS THERAPEUTICS PRIVATE LIMITED (IN) 2008-12-11 WO claimed
EP-2155720-B1 PYRROLE-2-CARBOXAMIDE DERIVATIVES AS GLUCOKINASE ACTIVATORS, THEIR PROCESS AND PHARMACEUTICAL APPLICATION ADVINUS THERAPEUTICS PRIVATE LTD (IN) 2013-07-17 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100292143-A1 PYRROLE-2-CARBOXAMIDE DERIVATIVES AS GLUCOKINASE ACTIVATORS, THEIR PROCESS AND PHARMACEUTICAL APPLICATION GCK, PCK1, GCKR MEN1 4123/4885KMT2A 1673/4885ALDH1A1 1904/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.